Summary
Amgen Inc. (AMGN) filed an 8-K on August 10, 2005, to announce a significant change in its principal accounting officer role. Michael A. Kelly was appointed as Vice President, Corporate Planning & Control and Chief Accounting Officer, effective August 10, 2005. This appointment was made by the Board of Directors on July 12, 2005, with the filing delayed until after the public press release. The report details Mr. Kelly's background and compensation, including his base salary and eligibility for incentive plans. Also noted is the resignation of Timothy O. Martin from the Chief Accounting Officer position to take on new responsibilities as Vice President, Finance for Global Commercial Operations.
Key Highlights
- 1Amgen appointed Michael A. Kelly as Vice President, Corporate Planning & Control and Chief Accounting Officer, effective August 10, 2005.
- 2Mr. Kelly's prior experience includes finance leadership roles at Tanox, Inc. and Biogen, Inc.
- 3Mr. Kelly's compensation includes a base salary of $306,338 and eligibility for the Management Incentive Plan (MIP).
- 4A personal loan of $360,000 made to Mr. Kelly in March 2003 remains outstanding.
- 5Timothy O. Martin resigned as Chief Accounting Officer but will assume a new role as VP, Finance for Global Commercial Operations.
- 6The filing includes a press release dated August 10, 2005, as Exhibit 99.1.